Physician profile
Michael Drelles
NPI 1518086560
$3,128.46
in general payments reported to CMS, 2019-2025
22 companies · $484 in 2025
The $484 reported for 2025 was more than what 84% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $1,387 · 2021: $205 · 2022: $235 · 2023: $149 · 2024: $458 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076 · Education: $15.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,075.73 |
| Education | $15.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,126.09 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Intracept Rf Probe |
| Vertos Medical, INC. | $124.00 | 2021 | |
| Nevro Corp. | $107.93 | 2019-2022 | |
| Saluda Medical Americas, INC. | $105.53 | 2024-2025 | Evoke |
| Scilex Pharmaceuticals INC. | $84.08 | 2019-2021 | |
| Spr Therapeutics, INC | $70.62 | 2021-2024 | Sprint Pns System |
| Nalu Medical, INC. | $61.50 | 2022-2024 | Nalu Neurostimulation System |
| Curonix LLC | $52.12 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $49.46 | 2023-2024 | Painteq |
| Ferring Pharmaceuticals INC. | $46.45 | 2022-2024 | Euflexxa |
| Depuy Synthes Sales INC. | $42.64 | 2022-2023 | Orthovisc, Monovisc, Peak |
| Pfizer INC. | $38.62 | 2019 | |
| Lilly USA, LLC | $34.29 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.90 | 2019-2024 | Relistor |
| Allergan, INC. | $24.44 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $23.06 | 2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $22.22 | 2022 | |
| Stimwave Technologies Incorporated | $19.14 | 2022 | |
| Abbvie INC. | $18.86 | 2021 | |
| Pinnacle, INC | $15.83 | 2025 | |
| Horizon Therapeutics Plc | $15.59 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Drelles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.